4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-023792
Options or other derivatives
- Director returned 322,500 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kaye Edward M. MD Director | 2025-09-04 | Returned to the company · Employee Stock Option (Right to Buy) | −178,500 | 37,500 | D | ||
| Kaye Edward M. MD Director | 2025-09-04 | Returned to the company · Restricted Stock Units | −144,000 | 0 | D | ||
Loading xslF345X05/form4-09052025_080918.xml…